Figure 2.
The inhibitors related to TSC2-mTOR axis active in preclinical and clinical trials. Black arrows indicate stimulation and red blocked arrows indicate inhibition. Abbreviations: HER2, human epidermal growth factor receptor 2; PI3K, phosphatidylinositol 3-kinase; AKT, protein kinase B; TSC1/2, tuberous sclerosis protein complex 1 and 2; mTORC1, mechanistic target of rapamycin complex 1; AMPK, AMP-activated protein kinase; CDK4, cyclin D-dependent kinase 4.
